CADI-T4021

CADI-T4021 is a therapeutic protocol developed by Bio-Modeling Systems (BMS) in collaboration with Arbuza Regenerate and the Indian Institute of Science Education and Research (IISER). Designed to address the long-term developmental consequences of childhood malnutrition, the protocol targets specific epigenetic and metabolic mechanisms during pregnancy. It is particularly focused on the Indian context, aiming to mitigate conditions such as chronic anaemia, wasting, stunting, and the 'thin-fat' phenotype in newborns, which are precursors to later metabolic and cardiovascular disorders. The program was discovered using BMS's proprietary CADI Discovery platform, which utilizes mechanisms-based modeling to identify therapeutic interventions for complex physiological dysregulations.

Other names

UMANG protocol